Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 5, 2009, Pages

  Harris, Laura ^a   Senagore, Patricia ^a,c   Young, Vincent B ^d   McCabe, Laura R ^a,b,e  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e NONE   (United States)

Author keywords

Adipocyte; Cartilage; Growth plate; Ulcerative colitis

Indexed keywords

SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; DEXTRAN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DISEASE; BONE STRENGTH; CARTILAGE CELL; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; ENTERITIS; GROWTH PLATE; MALE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; THICKNESS; TRABECULAR BONE; ACUTE DISEASE; ADIPOCYTE; ANIMAL; BLOOD; BONE; BONE REMODELING; C57BL MOUSE; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; DISEASE MODEL; DOWN REGULATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; TIME;

ACUTE DISEASE; ADIPOCYTES; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE REMODELING; CELL DIFFERENTIATION; CHONDROCYTES; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; RECOVERY OF FUNCTION; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66149119760     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90696.2008     Document Type: Article

References (72)

1. Ahdjoudj S, Lasmoles F, Holy X, Zerath E, Marie PJ. Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma. J Bone Miner Res 17: 668-677, 2002. (Pubitemid 34246642)
2. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 247: 63-70, 2000. (Pubitemid 30073165)
3. Armour KE, Van'T Hof RJ, Grabowski PS, Reid DM, Ralston SH. Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 14: 2137-2142, 1999.
4. Ashcroft AJ, Cruickshank SM, Croucher PI, Perry MJ, Rollinson S, Lippitt JM, Child JA, Dunstan C, Felsburg PJ, Morgan GJ, Carding SR. Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. Immunity 19: 849-861, 2003. (Pubitemid 37542305)
5. Ates Y, Degertekin B, Erdil A, Yaman H, Dagalp K. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. Dig Dis Sci 53: 2215-2221, 2008.
6. Bartram SA, Peaston RT, Rawlings DJ, Walshaw D, Francis RM, Thompson NP. Multifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World J Gastroenterol 12: 5680-5686, 2006. (Pubitemid 44594044)
7. Benjamin J, Makharia GK, Kalaivani M, Joshi YK. Nutritional status of patients with Crohn's disease. Indian J Gastroenterol 27: 195-200, 2008.
8. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124: 795-841, 2003.
9. Bernstein M, Irwin S, Greenberg GR. Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease. Am J Gastroenterol 100: 2031-2035, 2005. (Pubitemid 43919396)
10. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 40: 228-233, 1997. (Pubitemid 27093099)
11. Bleich A, Mahler M, Most C, Leiter EH, Liebler-Tenorio E, Elson CO, Hedrich HJ, Schlegelberger B, Sundberg JP. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome 15: 865-871, 2004. (Pubitemid 40064197)
12. Botolin S, McCabe LR. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99: 411-424, 2006. (Pubitemid 44435559)
13. Botolin S, McCabe LR. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss. J Cell Physiol 209: 967-976, 2006. (Pubitemid 44665719)
14. Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, Walker-Smith JA, MacDonald TT. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106: 1455-1466, 1994. (Pubitemid 24163114)
15. Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 19: 1961-1968, 2004. (Pubitemid 41103410)
16. Choi K, Roh SG, Hong YH, Shrestha YB, Hishikawa D, Chen C, Kojima M, Kangawa K, Sasaki S. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 144: 754-759, 2003. (Pubitemid 36262842)
17. Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127: 792-801, 2004. (Pubitemid 39208412)
18. Eivindson M, Nielsen JN, Gronbaek H, Flyvbjerg A, Hey H. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease. Horm Res 64: 9-15, 2005. (Pubitemid 41207072)
19. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70, 2003. (Pubitemid 36020767)
20. Fukushima N, Hanada R, Teranishi H, Fukue Y, Tachibana T, Ishikawa H, Takeda S, Takeuchi Y, Fukumoto S, Kangawa K, Nagata K, Kojima M. Ghrelin directly regulates bone formation. J Bone Miner Res 20: 790-798, 2005. (Pubitemid 40571636)
21. Gat-Yablonski G, Phillip M. Leptin and regulation of linear growth. Curr Opin Clin Nutr Metab Care 11: 303-308, 2008.
22. Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277: 2695-2701, 2002.
23. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 114: 902-911, 1998. (Pubitemid 28217555)
24. Hamdani G, Gabet Y, Rachmilewitz D, Karmeli F, Bab I, Dresner-Pollak R. Dextran sodium sulfate-induced colitis causes rapid bone loss in mice. Bone 43: 945-950, 2008.
25. Hock JM, Krishnan V, Onyia JE, Bidwell JP, Milas J, Stanislaus D. Osteoblast apoptosis and bone turnover. J Bone Miner Res 16: 975-984, 2001. (Pubitemid 32467141)
26. Hyams JS, Wyzga N, Kreutzer DL, Justinich CJ, Gronowicz GA. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr 24: 289-295, 1997. (Pubitemid 27199618)
27. Jiang J, Lichtler AC, Gronowicz GA, Adams DJ, Clark SH, Rosen CJ, Kream BE. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 39: 494-504, 2006. (Pubitemid 44149270)
28. Katsanos KH, Tsatsoulis A, Christodoulou D, Challa A, Katsaraki A, Tsianos EV. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease. Growth Horm IGF Res 11: 364-367, 2001. (Pubitemid 34428879)
29. Krawitt EL, Beeken WL, Janney CD. Calcium absorption in Crohn's disease. Gastroenterology 71: 251-254, 1976.
30. Lin CL, Moniz C, Chambers TJ, Chow JW. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology 111: 1263-1271, 1996. (Pubitemid 26362251)
31. Mahler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, Elson CO, Sundberg JP. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol Gastrointest Liver Physiol 274: G544-G551, 1998. (Pubitemid 28160553)
32. Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, Yang Z, Yi C, Quezado M, Brown M, Strober W. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology 131: 748-756, 2006. (Pubitemid 44307070)
33. Marino R, Hegde A, Barnes KM, Schrier L, Emons JA, Nilsson O, Baron J. Catch-up growth after hypothyroidism is caused by delayed growth plate senescence. Endocrinology 149: 1820-1828, 2008.
34. Martensson K, Chrysis D, Savendahl L. Interleukin-1beta and TNFalpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J Bone Miner Res 19: 1805-1812, 2004. (Pubitemid 41103431)
35. Martin LM, McCabe LR. Type I diabetic bone phenotype is location but not gender dependent. Histochem Cell Biol 128: 125-133, 2007.
36. McCabe LR. Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102: 1343-1357, 2007.
37. Melgar S, Bjursell M, Gerdin AK, Svensson L, Michaelsson E, Bohlooly YM. Mice with experimental colitis show an altered metabolism with decreased metabolic rate. Am J Physiol Gastrointest Liver Physiol 292: G165-G172, 2007. (Pubitemid 46090261)
38. Miheller P, Muzes G, Zagoni T, Toth M, Racz K, Tulassay Z. Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease. Dig Dis 24: 201-206, 2006. (Pubitemid 43747946)
39. Misra M, Miller KK, Cord J, Prabhakaran R, Herzog DB, Goldstein M, Katzman DK, Klibanski A. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 92: 2046-2052, 2007. (Pubitemid 46997099)
40. Motyl K, Botolin S, Irwin R, Appledorn D, Kadakia T, Amalfitano A, Schwartz R, McCabe L. Bone inflammation and altered gene expression with type I diabetes early onset. J Cell Physiol 218: 575-583, 2009.
41. Nanes MS. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321: 1-15, 2003.
42. Nicholls S, Stephens S, Braegger CP, Walker-Smith JA, MacDonald TT. Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea. J Clin Pathol 46: 757-760, 1993. (Pubitemid 23242431)
43. Niu T, Rosen CJ. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 361: 38-56, 2005. (Pubitemid 41506932)
44. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res 13:371-382, 1998. (Pubitemid 28146219)
45. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702, 1990. (Pubitemid 20069706)
46. Paganelli M, Albanese C, Borrelli O, Civitelli F, Canitano N, Viola F, Passariello R, Cucchiara S. Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 13: 416-423, 2007. (Pubitemid 46668246)
47. Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 12: 1162-1174, 2006.
48. Pazianas M, Rhim AD, Weinberg AM, Su C, Lichtenstein GR. The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease. Ann NY Acad Sci 1068: 543-556, 2006. (Pubitemid 43832924)
49. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 93: 1483-1490, 1998. (Pubitemid 29075187)
50. Pratt JS, Sachen KL, Wood HD, Eaton KA, Young VB. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun 74: 4496-4504, 2006.
51. Reid IR. Relationships between fat and bone. Osteoporos Int 19: 595-606, 2008.
52. Reimund JM, Arondel Y, Escalin G, Finck G, Baumann R, Duclos B. Immune activation and nutritional status in adult Crohn's disease patients. Dig Liver Dis 37: 424-431, 2005. (Pubitemid 44356050)
53. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94: 174-181, 1993. (Pubitemid 23308385)
54. Semeao EJ, Jawad AF, Zemel BS, Neiswender KM, Piccoli DA, Stallings VA. Bone mineral density in children and young adults with Crohn's disease. Inflamm Bowel Dis 5: 161-166, 1999.
55. Semeao EJ, Stallings VA, Peck SN, Piccoli DA. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology 112: 1710-1713, 1997.
56. Street ME, de'Angelis G, Camacho-Hubner C, Giovannelli G, Ziveri MA, Bacchini PL, Bernasconi S, Sansebastiano G, Savage MO. Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease. Horm Res 61: 159-164, 2004. (Pubitemid 38437684)
57. Sykora J, Subrt I, Didek P, Siala K, Schwarz J, Machalova V, Varvarovska J, Pazdiora P, Pozler O, Stozicky F. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-> A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 42: 479-487, 2006. (Pubitemid 43804724)
58. Sylvester FA. IBD and skeletal health: children are not small adults! Inflamm Bowel Dis 11: 1020-1023, 2005.
59. Sylvester FA, Davis PM, Wyzga N, Hyams JS, Lerer T. Are activated T cells regulators of bone metabolism in children with Crohn disease? J Pediatr 148: 461-466, 2006.
60. Sylvester FA, Wyzga N, Hyams JS, Davis PM, Lerer T, Vance K, Hawker G, Griffiths AM. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 13: 42-50, 2007. (Pubitemid 46080008)
61. Sylvester FA, Wyzga N, Hyams JS, Gronowicz GA. Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6. J Bone Miner Res 17: 695-702, 2002. (Pubitemid 34246645)
62. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, Wells T. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145: 234-242, 2004. (Pubitemid 38202164)
63. Tsukada Y, Nakamura T, Iimura M, Iizuka BE, Hayashi N. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis. Am J Gastroenterol 97: 2820-2828, 2002. (Pubitemid 35265434)
64. Van Hogezand RA, Hamdy NA. Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl: 59-64, 2006.
65. Van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology 125: 1591-1597, 2003. (Pubitemid 37500422)
66. Varghese S, Wyzga N, Griffiths AM, Sylvester FA. Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr 35: 641-648, 2002. (Pubitemid 35417735)
67. Verma S, Rajaratnam JH, Denton J, Hoyland JA, Byers RJ. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 55: 693-698, 2002.
68. Vidal VP, Chaboissier MC, Lutzkendorf S, Cotsarelis G, Mill P, Hui CC, Ortonne N, Ortonne JP, Schedl A. Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr Biol 15: 1340-1351, 2005. (Pubitemid 41097538)
69. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2: 541-546, 2007. (Pubitemid 47040018)
70. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110: 771-781, 2002.
71. Young VB, Knox KA, Pratt JS, Cortez JS, Mansfield LS, Rogers AB, Fox JG, Schauer DB. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun 72: 2521-2527, 2004.
72. Zhang X, Ziran N, Goater JJ, Schwarz EM, Puzas JE, Rosier RN, Zuscik M, Drissi H, O'Keefe RJ. Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 34:809-817, 2004. (Pubitemid 38581126)